NDC 83021-0839-07: Anubis Barcelona Propanediol, Glycerin, Magnesium Ascorbyl Phosphate .01035 g/1.5mL; .0003 g/1.5mL; 13576 .00285 g/1.5mL; .00135 g/1.5mL; 1.16659425 mL/1.5mL; .15 g/1.5mL; .00003 g/1.5mL; .000009 Concentrate, 1.5 mL Vial
This is a package of 1.5 mL of Anubis Barcelona Propanediol, Glycerin, Magnesium Ascorbyl Phosphate .01035 g/1.5mL; .0003 g/1.5mL; 13576 .00285 g/1.5mL; .00135 g/1.5mL; 1.16659425 mL/1.5mL; .15 g/1.5mL; .00003 g/1.5mL; .000009 Concentrate from ANUBIS COSMETICS SL, first listed with the FDA Oct 2022 and currently FDA-listed, this package's marketing is listed to end Jan 2027. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 83021-839-07 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 83021 labeler · 839 product · 07 package
- Package marketed since
- Oct 18, 2022
- Package marketing ended
- Jan 13, 2027
- Sample package
- No — commercial package
- Barcode (UPC)
- 8436019953839
- FDA record last changed
- Nov 19, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
Anubis Barcelona Propanediol, Glycerin, Magnesium Ascorbyl Phosphate is a topical concentrate marketed as an over-the-counter monograph product. It contains a blend of preservatives (benzoic acid, sorbic acid, dehydroacetic acid, and phenoxyethanol) that function to prevent microbial growth, along with humectants like glycerin and propanediol that are typically used to moisturize skin. The formulation also includes edetic acid, which is commonly used as a chelating agent, and various fragrance and sensory components. This product is intended for topical application and is regulated under the FDA's OTC monograph system.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 83021-0839-07 You're viewing this Main listing | 1.5 mL in 1 VIAL, SINGLE-USE | 2022-10-18 | Jan 13, 2027 | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Anubis Barcelona .01035 g/1.5mL; .0003 g/1.5mL; 13576 .00285 g/1.5mL; .00135 g/1.5mL; 1.16659425 mL/1.5mL; .15 g/1.5mL; .00003 g/1.5mL; .000009this 83021-0839-07 | ANUBIS | 1.5 ml | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
0.000105 g / 1.5 mL
UNII WAO5MNK9TU
Benzyl salicylate is a fragrant chemical compound used as a flavor and scent ingredient in medicines. It helps mask unpleasant tastes or odors in liquid or oral formulations.
-
0.00015 g / 1.5 mL
UNII 38H206R00R
A synthetic compound used as a skin-conditioning agent and preservative booster in topical formulations. It helps maintain product stability and may enhance the skin feel of creams or lotions.
-
0.00003 g / 1.5 mL
UNII H77VEI93A8
A synthetic yellow dye used to color medications. It helps identify the drug and make it visually distinctive, with no effect on how the medicine works.
-
0.0045 g / 1.5 mL
UNII 0R822556M5
A stabilized form of vitamin C derived from ascorbic acid and magnesium. It's used as an antioxidant and preservative to prevent ingredient degradation and extend shelf life in medications and supplements.
-
0.000009 g / 1.5 mL
UNII 1VPU26JZZ4
Potassium sorbate is a salt derived from sorbic acid, a naturally occurring preservative. It prevents growth of mold, yeast, and some bacteria, extending the medicine's shelf life.
-
0.000009 g / 1.5 mL
UNII OJ245FE5EU
Sodium benzoate is a salt derived from benzoic acid, a preservative. It's added to medicines to prevent growth of bacteria, fungi, and other microorganisms that could spoil the product.
6 inactive ingredients listed in the exact product block matched to this NDC.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from ANUBIS COSMETICS SL labeler code 83021
- Anubis Barcelona Regul OIl Peg-40 Hydrogenated Castor Oil, Propylene Glycol, Arctium Majus Root Extract 3.512 mL/10mL; 40 HYDROGENATED CASTOR OIL .04 g/10mL; .0345 g/10mL; .0138 g/10mL; .00007 g/10mL; .025 g/10mL; .0006 g/10mL; .0000002 g/10mL Concentrate NDC 83021-624-10
- Anubis Barcelona Protective Line Ethylhexyl Methoxycinnamate, Butyl Methoxydibenzoylmethane, Ethylhexyl Salicylate, Octocrylene 3.5982 g/50mL; .425 g/50mL; .1 g/50mL; 1.8 g/50mL; 2.5 g/50mL; 2.5 g/50mL; 2.1 g/50mL; 450000 MW) 27.55 mL/50mL; .575 g/50mL Cream NDC 83021-686-50
- Anubis Barcelona Total Hydrating Betaine, Glycerin, Polysorbate 20 5 g/250mL; 13576 .125 g/250mL; 1 .00025 g/250mL; 1.75 g/250mL; 5 g/250mL; 2.25 g/250mL; .125 g/250mL; 20 2.75 g/250mL; 232.139 mL/250mL; .75 Lotion NDC 83021-692-01
- Anubis Barcelona Regul Oil Propylene Glycol, Panthenol, Thiamine HCL 52.5 mL/250mL; .025 g/250mL; .25 g/250mL; .0225 g/250mL; .0025 g/250mL; 40 HYDROGENATED CASTOR OIL 2 g/250mL; .5 g/250mL; .14375 g/250mL Lotion NDC 83021-740-01
- Anubis Barcelona Regul Oil Cetearyl Ethylhexanoate, Propylene Glycol, Glyceryl Stearate Se .08784 g/200mL; .003398 g/200mL; .002132 g/200mL; 3.5436 mL/200mL; 1.6 g/200mL; 1.3 g/200mL; .1 g/200mL; .4 g/200mL; 155.839258 mL/200mL Cream NDC 83021-742-01
- ANUBISMED HA HYALURONIC .05 g/50mL; 2.5 g/50mL; 13576 .225 g/50mL; .875 g/50mL; .3 g/50mL; .0535 g/50mL; 1.996 g/50mL; .0038 g/50mL; .004 g/50mL Cream NDC 83021-750-50
- Anubis Barcelona Glycerin, Sorbitol, Aloe Barbadensis Leaf Juice .0525 g/1.5mL; .00075 g/1.5mL; 1.219341 mL/1.5mL; 1,2-HEXANEDIOL .0165 g/1.5mL; .16875 g/1.5mL; .000015 g/1.5mL; .0075 g/1.5mL; 1 .00000 Concentrate NDC 83021-877-07
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
7 Days Botox-like indications
⏱️ Dosage and Administration ▾
7 Days Botox-like administration
⚠️ Warnings ▾
7 Days Botox-like warnings
🧪 Active Ingredient ▾
7 Days Botox-like ingredients
🧪 Inactive Ingredients ▾
7 Days Botox-like ingredients list
🎯 Purpose ▾
7 Days Botox-like purpose
📄 Do Not Use ▾
7 Days Botox-like do not use
📄 Keep Out of Reach of Children ▾
7 Days Botox-like keep
📄 Package Label / Principal Display Panel ▾
7 Days Botox-like display
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |